- Home
- MYGN vs LION Comparison
MYGN vs LION Comparison
Compare MYGN & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- LION
- Stock Information
- Founded
- MYGN 1991
- LION 1997
- Country
- MYGN United States
- LION Canada
- Employees
- MYGN N/A
- LION N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LION Movies/Entertainment
- Sector
- MYGN Health Care
- LION Consumer Discretionary
- Exchange
- MYGN Nasdaq
- LION Nasdaq
- Market Cap
- MYGN 2.0B
- LION 2.0B
- IPO Year
- MYGN 1995
- LION N/A
- Fundamental
- Price
- MYGN $13.45
- LION $7.74
- Analyst Decision
- MYGN Hold
- LION Strong Buy
- Analyst Count
- MYGN 11
- LION 3
- Target Price
- MYGN $24.27
- LION $11.33
- AVG Volume (30 Days)
- MYGN 1.1M
- LION 357.3K
- Earning Date
- MYGN 02-25-2025
- LION 02-23-2025
- Dividend Yield
- MYGN N/A
- LION N/A
- EPS Growth
- MYGN N/A
- LION N/A
- EPS
- MYGN N/A
- LION N/A
- Revenue
- MYGN $823,600,000.00
- LION $2,983,500,000.00
- Revenue This Year
- MYGN $13.82
- LION $5.75
- Revenue Next Year
- MYGN $4.59
- LION $5.60
- P/E Ratio
- MYGN N/A
- LION N/A
- Revenue Growth
- MYGN 12.15
- LION N/A
- 52 Week Low
- MYGN $12.87
- LION $6.13
- 52 Week High
- MYGN $29.30
- LION $12.84
- Technical
- Relative Strength Index (RSI)
- MYGN 36.30
- LION 64.82
- Support Level
- MYGN $13.04
- LION $6.91
- Resistance Level
- MYGN $13.77
- LION $7.71
- Average True Range (ATR)
- MYGN 0.59
- LION 0.30
- MACD
- MYGN 0.17
- LION 0.05
- Stochastic Oscillator
- MYGN 36.96
- LION 87.38
About MYGN Myriad Genetics Inc.
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
About LION Lionsgate Studios Corp. Common Shares
Lionsgate Studios Corp is a company encompasses world-class motion picture and television studio operations and the STARZ-branded premium global subscription platforms to bring a unique and varied portfolio of entertainment to consumers around the world. The Studio Business consists of the Motion Picture and Television Production reportable segments, together with substantially all of Lionsgate's corporate general and administrative costs. Motion Picture consists of the development and production of feature films, acquisition of North American and worldwide distribution rights. Television Production consists of the development, production and worldwide distribution of television productions including television series, television movies and mini-series, and non-fiction programming.